<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>398916</identifier>
<setSpec>0210-5187</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Orozco, M A</dc:author>
<dc:author>Riera, C M</dc:author>
<dc:author>Galmarini, M</dc:author>
<dc:author>Ripoll, J</dc:author>
<dc:author>Katz, J</dc:author>
<dc:description xml:lang="en">In this work are presented results obtained in the treament of thirty patients suffering of lepromatous leprosy. In a group of fifteen patients L-tetramisol was administrated in association to antimocrobian drugs. The control group received only the last medication. Immunological modifications were not observed in any case. However, in six patients treated with L-tetramisol associated to rifampicin during three months it was possible to observe a notable improvement of the clinical state. In the patients that received L-tetramisol associated to other drugs or in those that received only antimicrobian drugs the clinical improvement was very low or null.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:date>1978 </dc:date>
<dc:title xml:lang="es">Acci√≥n del L-tetramisol asociado a la rifampicina en pacientes con lepra lepromatosa. L-tetramisol en pacientes con lepra lepromatosa.</dc:title>
<dc:title xml:lang="en">[Effect of L-tetramisol associated with rifampicin in patients with lepromatous leprosy. L-tetramisol in patients with lepromatous leprosy].</dc:title>
<dc:publisher>Medicina cutanea ibero-latino-americana</dc:publisher>
</metadata>
</record>
</pubmed-document>
